275 related articles for article (PubMed ID: 36747547)
1. Identification and validation of a five-gene prognostic signature based on bioinformatics analyses in breast cancer.
Du XJ; Yang XR; Wang QC; Lin GL; Li PF; Zhang WF
Heliyon; 2023 Feb; 9(2):e13185. PubMed ID: 36747547
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a N1-methyladenosine-related risk signature for breast carcinoma by bioinformatics analysis and experimental validation.
Li L; Yang W; Jia D; Zheng S; Gao Y; Wang G
Breast Cancer; 2023 Jul; 30(4):666-684. PubMed ID: 37178414
[TBL] [Abstract][Full Text] [Related]
3. Construction of a prognostic score model for breast cancer based on multi-omics analysis of study on bone metastasis.
Ren H; Shen X; Xie M; Guo X
Transl Cancer Res; 2024 May; 13(5):2419-2436. PubMed ID: 38881940
[TBL] [Abstract][Full Text] [Related]
4. Identification of a pyroptosis-related prognostic signature in breast cancer.
Chen H; Luo H; Wang J; Li J; Jiang Y
BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644
[TBL] [Abstract][Full Text] [Related]
5. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
[TBL] [Abstract][Full Text] [Related]
6. Construction and validation of a prognostic model based on stage-associated signature genes of head and neck squamous cell carcinoma: a bioinformatics study.
Chen L; Zhang X; Lin J; Wen Y; Chen Y; Chen CB
Ann Transl Med; 2022 Dec; 10(24):1316. PubMed ID: 36660709
[TBL] [Abstract][Full Text] [Related]
7. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma.
Yue C; Ma H; Zhou Y
PeerJ; 2019; 7():e8128. PubMed ID: 31803536
[TBL] [Abstract][Full Text] [Related]
8. Four-gene signature predicting overall survival and immune infiltration in hepatocellular carcinoma by bioinformatics analysis with RT‒qPCR validation.
Guan R; Zou J; Mei J; Deng M; Guo R
BMC Cancer; 2022 Jul; 22(1):830. PubMed ID: 35907846
[TBL] [Abstract][Full Text] [Related]
9. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma.
Wang L; Wang L; He P
Front Genet; 2022; 13():1064432. PubMed ID: 36568383
[No Abstract] [Full Text] [Related]
11. A Novel Inflammatory Response-Related Gene Signature Predicts Immune Status and Prognosis of Breast Cancer.
Zhao R; Xie C; Gong Y; Wei S; Yuan M; Gan J; Chen W
J Oncol; 2022; 2022():5468858. PubMed ID: 36467500
[TBL] [Abstract][Full Text] [Related]
12. Identification and Validation of Novel Metastasis-Related Immune Gene Signature in Breast Cancer.
Ma S; Hao R; Lu YW; Wang HP; Hu J; Qi YX
Breast Cancer (Dove Med Press); 2024; 16():199-219. PubMed ID: 38634039
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
14. Identification of a 5-Gene-Based Scoring System by WGCNA and LASSO to Predict Prognosis for Rectal Cancer Patients.
Huang H; Xu S; Chen A; Li F; Wu J; Tu X; Hu K
Anal Cell Pathol (Amst); 2021; 2021():6697407. PubMed ID: 33833937
[TBL] [Abstract][Full Text] [Related]
15. A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer.
Yang X; Weng X; Yang Y; Zhang M; Xiu Y; Peng W; Liao X; Xu M; Sun Y; Liu X
Aging (Albany NY); 2021 Aug; 13(15):19486-19509. PubMed ID: 34341184
[TBL] [Abstract][Full Text] [Related]
16. Identification of 9 Gene Signatures by WGCNA to Predict Prognosis for Colon Adenocarcinoma.
Yang M; He H; Peng T; Lu Y; Yu J
Comput Intell Neurosci; 2022; 2022():8598046. PubMed ID: 35392038
[TBL] [Abstract][Full Text] [Related]
17. Detecting prognostic biomarkers of breast cancer by regularized Cox proportional hazards models.
Li L; Liu ZP
J Transl Med; 2021 Dec; 19(1):514. PubMed ID: 34930307
[TBL] [Abstract][Full Text] [Related]
18. Cuproptosis/ferroptosis-related gene signature is correlated with immune infiltration and predict the prognosis for patients with breast cancer.
Li J; Zhang W; Ma X; Wei Y; Zhou F; Li J; Zhang C; Yang Z
Front Pharmacol; 2023; 14():1192434. PubMed ID: 37521466
[No Abstract] [Full Text] [Related]
19. Exploration of prognostic genes and risk signature in breast cancer patients based on RNA binding proteins associated with ferroptosis.
Chen X; Yang C; Wang W; He X; Sun H; Lyu W; Zou K; Fang S; Dai Z; Dong H
Front Genet; 2023; 14():1025163. PubMed ID: 36911389
[No Abstract] [Full Text] [Related]
20. Identification and Validation of an Immunological Expression-Based Prognostic Signature in Breast Cancer.
Pei J; Li Y; Su T; Zhang Q; He X; Tao D; Wang Y; Yuan M; Li Y
Front Genet; 2020; 11():912. PubMed ID: 33193571
[No Abstract] [Full Text] [Related]
[Next] [New Search]
